SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2

Zhou, Y; Fan, JJ; Zheng, CF; Yin, PR; Wu, HS; Li, XY; Luo, N; Yu, XQ; Chen, CS

Chen, CS (reprint author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Nephrol, Wenzhou 325000, Peoples R China.

BIOMEDICINE & PHARMACOTHERAPY, 2019; 109 (): 1327

Abstract

Background: Sodium glucose cotransporter-2 (SGLT-2) inhibitors have been widely used in the clinic to reduce blood glucose levels by enhancing glucose......

Full Text Link